Illustration: Brendan Lynch/Axios
New Mountain Capital will sell medical device materials maker ILC Dover to Ingersoll Rand for $2.3 billion.
Why it matters: ILC will sell for a 17x EBITDA multiple before earn-outs — a rich valuation indicating the ongoing interest in life sciences.